Yondelis Nueva Espectativa . Existe ya Prueba de Concepto de que Trabectedin Puede Actuar de Policia Bueno y Cargarse a los Policias Corruptos ( Fagocitos ) que en lugar de Atacar a la celulas Cancerigenas ... Permiten que estas Crezcan y se expandan ( Metastasis ) .

P.J. : Datos que demuestran la actividad específica de 'Yondelis' sobre el microambiente tumoral, concretamente reduciendo los macrófagos asociados al tumor.

Así, además de inducir la muerte de las células tumorales, 'Yondelis' actúa deplecionando los macrófagos asociados al tumor. Estas células, que normalmente forman parte del sistema inmunológico, tienen en el tumor una actividad protumoral ya que liberan una serie de factores que estimulan la división de las células tumorales así como la formación de neovasos.

Al inducir la muerte de éstas células, 'Yondelis' inhibe esta actividad protumoral y disminuye la secreción de los factores estimulantes del crecimiento tumoral. Este mecanismo de acción es particular a 'Yondelis' y no se observa con ninguna de los otros agentes antitumorales estudiados.

**************************************************

Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.

July 2015

Bonavita E1, Galdiero MR2, Jaillon S1, Mantovani A3.

Author information1IRCCS Istituto Clinico Humanitas, Rozzano, Italy.2IRCCS Istituto Clinico Humanitas, Rozzano, Italy; Division of Clinical Immunology and Allergy, University of Naples Federico II, Naples, Italy.3IRCCS Istituto Clinico Humanitas, Rozzano, Italy; Humanits University, Rozzano, Italy.

Abstract :

Inflammation is a key component of the tumor microenvironment. Tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs) are prototypic inflammatory cells in cancer-related inflammation. Macrophages provide a first line of resistance against infectious agents but in the ecological niche of cancer behave as corrupted policemen. TAMs promote tumor growth and metastasis by direct interactions with cancer cells, including cancer stem cells, as well as by promoting angiogenesis and tissue remodeling and suppressing effective adaptive immunity. In addition, the efficacy of chemotherapy, radiotherapy, and checkpoint blockade inhibitors is profoundly affected by regulation of TAMs. In particular, TAMs can protect and rescue tumor cells from cytotoxic therapy by orchestrating a misguided tissue repair response. Following extensive preclinical studies, there is now proof of concept that targeting tumor-promoting macrophages by diverse strategies (e.g., Trabectedin, anti-colony-stimulating factor-1 receptor antibodies) can result in antitumor activity in human cancer and further studies are ongoing. Neutrophils have long been overlooked as a minor component of the tumor microenvironment, but there is evidence for an important role of TANs in tumor progression. Targeting phagocytes (TAMs and TANs) as corrupted policemen in cancer may pave the way to innovative therapeutic strategies complementing cytoreductive therapies and immunotherapy